Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02641899 · ClinicalTrials.gov registry record · Phase 1
Study of the Effects of ITCA 650 on Gastric Emptying and Interaction of ITCA 650 on 4 Commonly Studied Drugs
A Phase 1 study, sponsored by Intarcia Therapeutics.
- Completed
- Registry status
- Phase 1
- Development phase
- 33
- Enrollment target
NCT02641899 is a Phase 1 study that has completed, run by Intarcia Therapeutics. The registered enrollment target is 33 participants.
The verdict
NCT02641899, a Phase 1 study, has completed, sponsored by Intarcia Therapeutics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 33 participants
- Enrollment target
Study Summary
A Phase 1, Fixed-Sequence, Open-label Study in Healthy Subjects to Estimate the Effects of ITCA 650 on Gastric Emptying and on the Absorption Pharmacokinetics of Each of 4 Commonly Studied DDI Probe Compounds.
Interventions
- DRUG Acetaminophen
- DRUG Atorvastatin
- DRUG Warfarin
- DRUG Lisinopril
- DRUG ITCA 650 20/60 mcg/day
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2015-12 |
| Est. Completion | 2016-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02641899
The ClinicalTrials.gov registry entry for NCT02641899 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Intarcia Therapeutics, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Acetaminophen is the first listed.
NCT02641899 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02641899 about?
NCT02641899 is a clinical study titled "Study of the Effects of ITCA 650 on Gastric Emptying and Interaction of ITCA 650 on 4 Commonly Studied Drugs". A Phase 1, Fixed-Sequence, Open-label Study in Healthy Subjects to Estimate the Effects of ITCA 650 on Gastric Emptying and on the Absorption Pharmacokinetics of Each of 4 Commonly Studied DDI Probe Compounds.
What is the current status of trial NCT02641899?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 33 participants. The study started on 2015-12. Estimated completion is 2016-03.
What interventions are being tested in trial NCT02641899?
The interventions under investigation include: Acetaminophen (DRUG), Atorvastatin (DRUG), Warfarin (DRUG), Lisinopril (DRUG), ITCA 650 20/60 mcg/day (DRUG).
Who is sponsoring clinical trial NCT02641899?
This trial is sponsored by Intarcia Therapeutics, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.